Clinical Trials in Baltimore

Showing 18701-18720 of 23,476 trials

Observational Study to Investigate the Melatonin and Cortisol Circadian Rhythms of Individuals With Smith-Magenis Syndrome (SMS)

NCT02180451

The purpose of this study is to characterize the circadian rhythm disruption experienced by patients as determined by plasma melatonin, cortisol, and other circadian analytes

Smith Magenis Syndrome

Vanda Pharmaceuticals8 participantsStarted Jun 2014

Baltimore, Maryland, United States

COMPLETED< 1 mile

Retrospective Multicenter Study to Determine 4-Year Clinical Outcomes in Subjects Previously Enrolled in the CTOT-05 Study

NCT02255123

This study is a multicenter, non-randomized, retrospective study to collect long term (4 years post-transplant) clinical outcome data on subjects previously enrolled in the CTOT-05 study (NCT00466804) to evaluate participant and graft survival.

Cardiac Transplantation

National Institute of Allergy and Infectious Diseases (NIAID)178 participantsStarted Oct 2014

San Francisco, California, United States • Chicago, Illinois, United States • Maywood, Illinois, United States +9 more locations

TERMINATEDPhase 3< 1 mile

Evaluation of Weekly Idrabiotaparinux Sodium Versus Oral Adjusted-dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation

NCT00580216

The objective is to evaluate whether once weekly subcutaneous (SC) injection of idrabiotaparinux sodium (biotinylated idraparinux) is at least as efficient to prevent clots in brain and in the other organs than oral international normalized ratio (INR) adjusted-dose warfarin in patients with atrial fibrillation (AF).

Atrial Fibrillation

Sanofi3,773 participantsStarted Dec 2007

Mobile, Alabama, United States • Tucson, Arizona, United States • Little Rock, Arkansas, United States +535 more locations

Observational Study to Investigate the Melatonin and Cortisol Circadian Rhythms of Individuals With Smith-Magenis Syndrome (SMS)

Retrospective Multicenter Study to Determine 4-Year Clinical Outcomes in Subjects Previously Enrolled in the CTOT-05 Study

Evaluation of Weekly Idrabiotaparinux Sodium Versus Oral Adjusted-dose Warfarin to Prevent Stroke and Systemic Thromboembolic Events in Patients With Atrial Fibrillation

Find Trials by Condition in Baltimore

Efficacy and Safety of GLYX-13 in Subjects With Inadequate/Partial Response to Antidepressants

Randomized Trial of Suicide Gene Therapy and Prostate Cancer

Study of the Safety, Tolerability, and Pharmacokinetics of Once Weekly Zicronapine in Patients With Schizophrenia

Effect of Electrical Stimulation (DC Polarization) to the Brain on Memory

Vasodilators and Anti-Oxidant Therapy in Early ATN

A Study of Investigational SAR245409 in Patients With Certain Lymphoma or Leukemia

Clinical Study Assessing Idrabiotaparinux Sodium Injections Once-weekly in Pulmonary Embolism Therapeutic Approach

Bioequipotency Study of Idrabiotaparinux and Idraparinux in Patients With Deep Venous Thrombosis of the Lower Limbs

A Pharmacokinetic Study of Single-Dose Intravenous Ustekinumab Delivered in 2 Different Liquid in Vial Formulations

Long-term, Safety and Tolerability Study of AFQ056 in Adolescent Patients With Fragile X Syndrome (Open-label)

The Efficacy and Safety of Atacicept in Combination With Mycophenolate Mofetil Used to Treat Lupus Nephritis

Performance of the ePrime System for Cellulite

Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).

Cognitive Function and Fatigue in Colorectal Cancer (CRC) Patients After Chemotherapy

A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0973 in Combination With GDC-0068 When Administered in Participants With Locally Advanced or Metastatic Solid Tumors

Bioequivalence Study of IG-001 Versus Nab-paclitaxel in Metastatic or Locally Recurrent Breast Cancer

Clinical Outcomes and Safety: A Registry Study of Ilaris (Canakinumab) Patients